These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 23992163)

  • 61. Androgenetic alopecia in men: the scale of the problem and prospects for treatment.
    Rushton DH
    Int J Clin Pract; 1999; 53(1):50-3. PubMed ID: 10344067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study.
    Pekmezci E; Dündar C; Türkoğlu M
    Acta Dermatovenerol Alp Pannonica Adriat; 2018 Jun; 27(2):51-57. PubMed ID: 29945259
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females.
    Peereboom-Wynia JD; van der Willigen AH; van Joost T; Stolz E
    Acta Derm Venereol; 1989; 69(5):395-8. PubMed ID: 2572103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Tanglertsampan C
    J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Possible mechanisms of miniaturization during androgenetic alopecia or pattern hair loss.
    Whiting DA
    J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S81-6. PubMed ID: 11511857
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of androgenetic alopecia.
    Tosti A; Camacho-Martinez F; Dawber R
    J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibitory autocrine factors produced by the mesenchyme-derived hair follicle dermal papilla may be a key to male pattern baldness.
    Hamada K; Randall VA
    Br J Dermatol; 2006 Apr; 154(4):609-18. PubMed ID: 16536801
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Therapeutic approaches to the management of common baldness.
    Sommer M; Wilson C
    Int J Clin Pract; 1999; 53(5):381-5. PubMed ID: 10695105
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mechanism of action of herbs and their active constituents used in hair loss treatment.
    Herman A; Herman AP
    Fitoterapia; 2016 Oct; 114():18-25. PubMed ID: 27552901
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Status of scalp hair and therapy of alopecia in men in Switzerland].
    Trüeb RM; de Viragh PA;
    Praxis (Bern 1994); 2001 Feb; 90(7):241-8. PubMed ID: 11256223
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence for supplemental treatments in androgenetic alopecia.
    Famenini S; Goh C
    J Drugs Dermatol; 2014 Jul; 13(7):809-12. PubMed ID: 25007363
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A bibliometric study of scientific literature in Scopus on botanicals for treatment of androgenetic alopecia.
    Rondanelli M; Perna S; Peroni G; Guido D
    J Cosmet Dermatol; 2016 Jun; 15(2):120-30. PubMed ID: 26608588
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Over-the-Counter Hair Loss Treatments: Help or Hype?
    Bater K; Rieder E
    J Drugs Dermatol; 2018 Dec; 17(12):1317-1321. PubMed ID: 30586264
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exploring the combination and modular characteristics of herbs for alopecia treatment in traditional Chinese medicine: an association rule mining and network analysis study.
    Leem J; Jung W; Kim Y; Kim B; Kim K
    BMC Complement Altern Med; 2018 Jul; 18(1):204. PubMed ID: 29973199
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Male pattern hair loss: Can developmental origins explain the pattern?
    Redmond LC; Limbu S; Farjo B; Messenger AG; Higgins CA
    Exp Dermatol; 2023 Jul; 32(7):1174-1181. PubMed ID: 37237288
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alopecia and Hair Damage Induced by Oncological Therapy.
    Jedličková H; Vokurka S; Vojtíšek R; Malečková A
    Klin Onkol; 2019; 32(5):353-359. PubMed ID: 31610668
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel drug delivery approaches for the management of hair loss.
    Alsalhi W; Alalola A; Randolph M; Gwillim E; Tosti A
    Expert Opin Drug Deliv; 2020 Mar; 17(3):287-295. PubMed ID: 32003262
    [No Abstract]   [Full Text] [Related]  

  • 79. Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia.
    Hadshiew IM; Foitzik K; Arck PC; Paus R
    J Invest Dermatol; 2004 Sep; 123(3):455-7. PubMed ID: 15304082
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dexpanthenol may be a novel treatment for male androgenetic alopecia: Analysis of nine cases.
    Kutlu Ö
    Dermatol Ther; 2020 May; 33(3):e13381. PubMed ID: 32255530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.